Tryptophan oxidation in young children with environmental enteric dysfunction classified by the lactulose rhamnose

Nirupama Shivakumar1, Jean W Hsu2, Sindhu Kashyap1

  • 1Division of Nutrition, St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India.

Insights

Environmental enteric dysfunction (EED) in children does not alter tryptophan (Trp) oxidation but shows slower kynurenine (Kyn) synthesis. This suggests EED may not directly impair Trp availability for protein synthesis, contrary to previous hypotheses.

Area of Science:

  • Nutritional Biochemistry
  • Pediatric Gastroenterology
  • Metabolic Research

Background:

  • Linear growth faltering in young children is linked to environmental enteric dysfunction (EED) and altered plasma kynurenine (Kyn)/tryptophan (Trp) ratio (KTR).
  • A proposed mechanism involves increased Trp catabolism due to inflammation, reducing Trp for protein synthesis and thus impairing growth.

Purpose of the Study:

  • To quantify Trp oxidation rates in children with and without EED.
  • To determine Trp conversion rates to Kyn in young children with and without EED.

Main Methods:

  • Children aged 18-24 months from urban slums were categorized into EED (n=19) and no-EED (n=26) groups based on urinary lactulose/rhamnose ratio (LRR).
  • Plasma KTR and fecal EED biomarkers were measured.
  • Fed-state Trp oxidation was assessed using 13C1-Trp oral plateau feeding.

Main Results:

  • No significant difference in fed-state Trp oxidation or Trp availability for protein synthesis between EED and no-EED groups.
  • Significantly slower fractional synthesis rates of Kyn and reduced fraction of alanine derived from Trp in the plasma compartment for the EED group.
  • Fasted KTR was higher in the EED group, but this did not correlate with altered Trp oxidation.

Conclusions:

  • Static plasma KTR is an unreliable indicator of dynamic Trp flux through the oxidative pathway.
  • In poor sanitary environments, children without EED exhibit faster Kyn synthesis, potentially offering cytoprotective and anti-inflammatory benefits.
  • The study was registered with the Clinical Trials Registry of India (CTRI/2017/02/007921).
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
239
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
322
Repressible Operon: trp Operon01:21

Repressible Operon: trp Operon

The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
135
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
395